Catheter receives notification of new patent issuance for VIVO product line

Catheter Precision (VTAK) announced that it has received notification from the Unites States Patent and Trademark Office for issuance of a new a VIVO patent titled Methods of Ventricular Arrhythmia Localization Using a 3D Heart Model. This patent is in addition to several already granted patents for VIVO. David Jenkins, CEO of Catheter Precision, said, “Patents and trademarks are an integral part of our business activities. We strive for VIVO to be used as a tool to easily identify ventricular arrhythmias noninvasively and provide the physician with additional information before the procedure. This new patent allows us to continue advancing methods of identification and providing physicians with the information they need to successfully treat patients while adding to our growing IP portfolio.”